103 related articles for article (PubMed ID: 30389627)
1. Synthesis and characterization of 20-hydroxyvitamin D
Fujishima T; Suenaga T; Kawahata M; Yamaguchi K
J Steroid Biochem Mol Biol; 2019 Mar; 187():27-33. PubMed ID: 30389627
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activity of novel vitamin D analogues: 24,24-difluoro-25-hydroxy-26,27-dimethylvitamin D3 and 24,24-difluoro-1 alpha,25-dihydroxy-26,27-dimethylvitamin D3.
Gill HS; Londowski JM; Corradino RA; Zinsmeister AR; Kumar R
J Med Chem; 1990 Feb; 33(2):480-90. PubMed ID: 2153815
[TBL] [Abstract][Full Text] [Related]
3. Total synthesis of biologically active 20S-hydroxyvitamin D3.
Wang Q; Lin Z; Kim TK; Slominski AT; Miller DD; Li W
Steroids; 2015 Dec; 104():153-62. PubMed ID: 26433048
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis and Biological Activities of Novel Gemini 20S-Hydroxyvitamin D3 Analogs.
Lin Z; Marepally SR; Kim TK; Janjetovic Z; Oak AS; Postlethwaite AE; Myers LK; Tuckey RC; Slominski AT; Miller DD; Li W
Anticancer Res; 2016 Mar; 36(3):877-86. PubMed ID: 26976974
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 2α- and 2β-(3-hydroxypropyl)- 7,8-cis-14-epi-1α,25-dihydroxy-19-norvitamin D
Sawada D; Ochiai E; Takeuchi A; Kakuda S; Kamimura-Takimoto M; Kawagoe F; Kittaka A
J Steroid Biochem Mol Biol; 2017 Oct; 173():79-82. PubMed ID: 27629592
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Biological Activity of 25-Hydroxy-2-methylene-vitamin D3 analogues monohydroxylated in the A-ring.
Sibilska IK; Sicinski RR; Ochalek JT; Plum LA; DeLuca HF
J Med Chem; 2014 Oct; 57(20):8319-31. PubMed ID: 25221942
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of the CYP24A1 major metabolite of 2α-[2-(tetrazol-2-yl)ethyl]-1α,25-dihydroxyvitamin D
Takano M; Yasuda K; Tohyama E; Higuchi E; Sakaki T; Kittaka A
J Steroid Biochem Mol Biol; 2017 Oct; 173():75-78. PubMed ID: 27923594
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of vitamin D3 analogues with A-ring modifications to directly measure vitamin D levels in biological samples.
Hernández-Martín A; González-García T; Lawlor M; Preston L; Gotor V; Fernández S; Ferrero M
Bioorg Med Chem; 2013 Dec; 21(24):7779-89. PubMed ID: 24216092
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and metabolic studies of 1α,2α,25-, 1α,4α,25- and 1α,4β,25-trihydroxyvitamin D3.
Takano M; Sawada D; Yasuda K; Nishikawa M; Takeuchi A; Takagi K; Horie K; Reddy GS; Chen TC; Sakaki T; Kittaka A
J Steroid Biochem Mol Biol; 2015 Apr; 148():34-7. PubMed ID: 25263656
[TBL] [Abstract][Full Text] [Related]
10. Isolation and identification of 2alpha,25-dihydroxyvitamin D3, a new metabolite from Pseudonocardia autotrophica 100U-19 cells incubated with Vitamin D3.
Takeda K; Kominato K; Sugita A; Iwasaki Y; Shimazaki M; Shimizu M
Steroids; 2006 Aug; 71(8):736-44. PubMed ID: 16784761
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and binding-analysis of 5E-[19-(2-bromoacetoxy)methyl]25-hydroxyvitamin D3 and 5E-25-hydroxyvitamin D3-19-methyl[(4-azido-2-nitro)phenyl]glycinate: novel C19-modified affinity and photoaffinity analogs of 25-hydroxyvitamin D3.
Addo JK; Ray R
Steroids; 1998 Apr; 63(4):218-23. PubMed ID: 9589557
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of 2α-(tetrazolylethyl)-1α,25-dihydroxyvitamin D3 as a high affinity ligand for vitamin D receptor.
Matsuo M; Hasegawa A; Takano M; Saito H; Kakuda S; Takagi K; Ochiai E; Horie K; Takimoto-Kamimura M; Takenouchi K; Sawada D; Kittaka A
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():201-3. PubMed ID: 24036313
[TBL] [Abstract][Full Text] [Related]
13. The First Convergent Synthesis of 23,23-Difluoro-25-hydroxyvitamin D
Mototani S; Kawagoe F; Yasuda K; Mano H; Sakaki T; Kittaka A
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014588
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective Synthesis of 24-Fluoro-25-Hydroxyvitamin D
Kawagoe F; Mototani S; Yasuda K; Mano H; Sakaki T; Kittaka A
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769295
[TBL] [Abstract][Full Text] [Related]
15. Novel 2-alkyl-1alpha,25-dihydroxy-19-norvitamin D3: efficient synthesis with Julia olefination, evaluation of biological activity and development of new analyzing system for co-activator recruitment.
Arai MA; Kittaka A
Anticancer Res; 2006; 26(4A):2621-31. PubMed ID: 16886672
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel 1,25-dihydroxyvitamin D3 analogues having a spiro-oxetane fused at the C2 position in the A-ring.
Fujishima T; Nozaki T; Suenaga T
Bioorg Med Chem; 2013 Sep; 21(17):5209-17. PubMed ID: 23845283
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological properties of seco-d-ring modified 1α,25-dihydroxyvitamin D
Szybinski M; Sektas K; Sicinski RR; Plum LA; Frelek J; DeLuca HF
J Steroid Biochem Mol Biol; 2017 Jul; 171():144-154. PubMed ID: 28285018
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological action of 20R-hydroxyvitamin D3.
Lu Y; Chen J; Janjetovic Z; Michaels P; Tang EK; Wang J; Tuckey RC; Slominski AT; Li W; Miller DD
J Med Chem; 2012 Apr; 55(7):3573-7. PubMed ID: 22404326
[TBL] [Abstract][Full Text] [Related]
19. Novel vitamin D receptor ligands having a carboxyl group as an anchor to arginine 274 in the ligand-binding domain.
Fujishima T; Tsuji G; Tanaka C; Harayama H
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):60-2. PubMed ID: 20435140
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 25-hydroxyvitamin D(3) and 26,26,26,27,27,27-hexadeutero-25-hydroxyvitamin D(3) on solid support.
Nicoletti D; Mouriño A; Torneiro M
J Org Chem; 2009 Jul; 74(13):4782-6. PubMed ID: 19492827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
